CN Patent

CN104513253A — 用于治疗增殖性疾病的大环化合物

Assigned to Beijing Xuan Yi medical science and Technology Co., Ltd. · Expires 2015-04-15 · 11y expired

What this patent protects

本发明的化合物和盐抑制激酶，尤其是间变性淋巴瘤激酶（ALK）和HGF受体酪氨酸激酶（RTK）c-Met，并可用于治疗或改善异常细胞增殖性疾病，如癌症。

USPTO Abstract

本发明的化合物和盐抑制激酶，尤其是间变性淋巴瘤激酶（ALK）和HGF受体酪氨酸激酶（RTK）c-Met，并可用于治疗或改善异常细胞增殖性疾病，如癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN104513253A
Jurisdiction
CN
Classification
—
Expires
2015-04-15
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Xuan Yi medical science and Technology Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.